Sources | Names Used |
---|---|
CTRPv2 | BRD-K61166597 |
PharmacoGx | BRD-K61166597 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADPRHL1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | BTD | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | NTNG2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | FMR1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | FEM1A | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | ZNF318 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | CLDN17 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | GOLGA2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | MDFIC | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | IRF2BPL | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |